Lisa Dvorak

Translational Evaluation of JNJ-18038683, a 5-Hydroxytryptamine Type 7 Receptor Antagonist, on Rapid Eye Movement Sleep and in Major Depressive Disorder

Pascal Bonaventure, Christine Dugovic, Michelle Kramer et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 86 citations

Medicine, Pharmacology, Psychiatry +16

Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists

Joshua Wollam, Michelle Solomon, Christiane Villescaz et al. · Journal of Allergy and Clinical Immunology · 2024 · 65 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Lead identification of acetylcholinesterase inhibitors–histamine H3 receptor antagonists from molecular modeling

Scott D. Bembenek, John M. Keith, Michael A. Letavic et al. · Bioorganic & Medicinal Chemistry · 2007 · 57 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptor

James R. Shoblock, Natalie Welty, Diane Nepomuceno et al. · Psychopharmacology · 2009 · 52 citations

Life Sciences, Neuroscience, Pharmacology +14

Pharmacological characterization of JNJ-28583867, a histamine H3 receptor antagonist and serotonin reuptake inhibitor

Ann Barbier, Leah Aluisio, Brian Lord et al. · European Journal of Pharmacology · 2007 · 45 citations

Medicine, Pharmacology, Neuropharmacology +12